Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research-Reference-Cited by-同舟云学术

Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research

Published:2022-09 Issue: Volume:49 Page:102365
ISSN:1477-8939
Container-title:Travel Medicine and Infectious Disease
language:en
Short-container-title:Travel Medicine and Infectious Disease

Author:

Schnyder Jenny L.^ORCID,de Jong Hanna K.,Schlagenhauf Patricia,Borrmann Steffen,Hanscheid Thomas,Grobusch Martin P.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference19 articles.

1. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria;Nakato;J Antimicrob Chemother,2007

2. Causal prophylactic efficacy of atovaquone-proguanil (MalaroneTM) in a human challenge model;Berman;Trans R Soc Trop Med Hyg,2001

3. Researches on Paludrine (M. 4888) in malaria. An experimental investigation undertaken by the LHQ medical research unit (AIF), Cairns, Australia;Fairley;Trans R Soc Trop Med Hyg,1946

4. Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro;Eriksson;Trans R Soc Trop Med Hyg,1991

5. Prophylactic activity of atovaquone against Plasmodium falciparum in humans;Shapiro;Am J Trop Med Hyg,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malaria;The Diagnosis and Treatment of Protozoan Diseases;2024

2. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives;Travel Medicine and Infectious Disease;2023-03